In-house roundup: How to manage AI applications; pharma unconcerned by NHS provision; fintech embraces open source

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

In-house roundup: How to manage AI applications; pharma unconcerned by NHS provision; fintech embraces open source

Drugs

Managing IP rounds up the latest news and analysis from patent-focused businesses



Drugs

How financial services firms manage AI applications

Counsel at Equifax, Morgan Stanley and American Express say streamlining relationships with external counsel and disclosing data sets correctly are key to prosecuting artificial intelligence patents. Read more... 

Pharma companies unconcerned by NHS notification in preliminary injunctions

In-house sources say changes to the England and Wales Patents Court Guide setting out that health authorities must be notified in the case of an injunction for an approved therapeutic product are not a cause for concern. Read more... 

Digital transformation pushes firms to embrace open source

Microsoft, JPMorgan and Wells Fargo explain how the cloud, AI and data sets technologies are driving them to open source and how that change is affecting patent strategies. Read more... 





more from across site and SHARED ros bottom lb

More from across our site

News of Health Hoglund joining Sisvel and the Delhi High Court staying a $2.2 million decree in favour of Philips were also among the top talking points
The firm is continuing its aggressive IP hiring streak with the addition of partner Matthew Rizzolo
Pantech counsel Shogo Matsunaga speaks exclusively to Managing IP about how his team proved Google’s unwillingness, and ultimately secured a landmark SEP settlement
New partners, including the firm’s first female head of a department, are eyeing a deeper focus on client understanding
Chunguang Hu of China PAT explains why his ‘insider’ experience as a patent examiner benefits clients and why he wants to debunk the myth that IP has limited value in China
Essenese Obhan shares his expansion plans and vision of creating a ‘one-stop shop’ for clients after Indian firms Obhan & Associates and Mason & Associates joined forces
From AI and the UPC to troublesome trademarks in China, experts name the IP trends likely to dominate 2026
Colm Murphy says he is keen to help clients navigate cross-border IP challenges in Europe
With 2025 behind us, US practitioners sit down with Managing IP to discuss the major IP moments from the year and what to expect in 2026
Large-scale transatlantic mergers will give US entities a strong foothold at the UPC, and could spark further fragmentation of European patent practices
Gift this article